Biotech Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million July 25, 2022
Biotech Agios to Webcast Conference Call of Second Quarter 2022 Financial Results on August 4, 2022 July 25, 2022
Biotech Cocrystal Pharma Reports CC-42344 Pharmacokinetic Data in Influenza A Once-Daily Dosing July 25, 2022
Biotech GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil July 25, 2022
Biotech UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients July 25, 2022